Onkologie. 2009:3(1):66-67

Advanced germ cell testicular tumour at teenage male

Michal Zápotocký, David Sumerauer, Hubert Mottl
Klinika dětské hematologie a onkologie, UK 2. LF a FN Motol, Praha

We present the case report of teenage patient with long history of palpable testicular resistance. At the time of diagnosis the mixed germinal

testicular tumour was advanced with much worse prognosis and more complicated treatment compared to localised tumour.

Keywords: germ cell tumour, testes, tumour markers.

Published: March 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zápotocký M, Sumerauer D, Mottl H. Advanced germ cell testicular tumour at teenage male. Onkologie. 2009;3(1):66-67.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Rogers PC, Olson TA, Cullen JW et al. Pediatric Oncology Group 9048; Children's Cancer Group 8891. Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study-Pediatric Oncology Group 9048 and Children's Cancer Group 8891. J Clin Oncol. 2004 Sep 1; 22(17): 3563-3569. Go to original source... Go to PubMed...
    2. Coppes MJ, Rackley R, Kay R. Primary testicular and paratesticular tumors of childhood. Med Pediatr Oncol. 1994; 22(5): 329-340. Go to original source... Go to PubMed...
    3. Bajčiová V, Štěrba J, Kadlecová V. Význam praktrického lékaře pro děti a dorost pro prevenci a časnou diagnostiku nádorů varlat u adolescentů. Výsledky pilotní studie u 1250 respondentů na Moravě, Postgraduální medicína, 2006; 8(3): 266-269.
    4. Cushing B, Giller R, Cullen JW, et al. Pediatric Oncology Group 9049; Children's Cancer Group 8882. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study - Pediatric Oncology Group 9049 and Children's Cancer Group 8882. J Clin Oncol. 2004 Jul 1; 22(13): 2691-2700. Go to original source... Go to PubMed...
    5. Malogolowkin M, London W, Fraizer L, Olson T. Brain metastases in childrens with high risk germ cell tumors (GCT). A report from the Childrens Oncology Group (COG). 40th Congress of the International Society of Paediatric Oncology 2008, Berlin, Germany.
    6. Frazier AL, Rumcheva P, Olson T, Giller et al. Children's Oncology Group. Application of the adult international germ cell classification system to pediatric malignant non-seminomatous germ cell tumors: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2008 Apr; 50(4): 746-751. Go to original source... Go to PubMed...
    7. Krege S, Beyer J, Souchon R, et al. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. Eur Urol. 2008 Mar; 53(3): 478-496. Go to original source... Go to PubMed...
    8. Krege S, Beyer J, Souchon R, et al. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. Eur Urol. 2008 Mar; 53(3): 497-513. Go to original source... Go to PubMed...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.